David Byram

GeneNews announced that it has appointed David Byram as Chief Commercial Officer for its US lab, Innovative Diagnostics Laboratory (IDL). Byram will oversee all of the IDL customer's-facing activities, including sales, client relations, and commercial operations. Prior to joining IDL, Byram was VP, commercial and government affairs for Braeburn Pharmaceuticals. Prior to Braeburn, Byram held positions as senior VP, commercial affairs for Orexo AB/US, US director, public sector for Indivior, and senior director, strategic accounts and public affairs for Janssen Biotech.